Test Code PCDSO
Pain Clinic Drug Screen, Urine

Useful For

Detection and identification of prescription or over-the-counter
drugs frequently found in drug overdose or used with a suicidal
intent

This test is intended to be used in a setting where the
identification of the drug is required.

Profile Information

Test ID

Reporting Name

Available Separately

Always Performed

CDAU7

Confirmed Drug Abuse Panel 9, U

Yes

Yes

OXYSU

Oxycodone Screen, U

Yes

Yes

PDSU

Drug Screen, Prescription/OTC, U

Yes

Yes

Reflex Tests

Test ID

Reporting Name

Available Separately

Always Performed

AMPHU

Amphetamines Confirmation, U

Yes

No

COKEU

Cocaine and metabolite Conf, U

Yes

No

BENZU

Benzodiazepines Confirmation, U

Yes

No

BARBU

Barbiturates Confirmation, U

Yes

No

MTDNU

Methadone Confirmation, U

Yes

No

PCPU

Phencyclidine Confirmation, U

Yes

No

THCU

Carboxy-THC Confirmation, U

Yes

No

ETOH

Ethanol, U

No

No

OPATU

Opiate Confirmation, U

Yes

No

OXYCU

Oxycodone w/metabolite Conf, U

Yes

No

Testing Algorithm

Testing begins with screening tests for alcohol and drugs of
abuse. Positives are confirmed and quantitated by definitive
methods (gas chromatography-flame ionization detector for ethanol;
gas chromatography-mass spectrometry for barbiturates,
benzodiazepines, cocaine and metabolites, methadone, phencyclidine,
and tetrahydrocannabinol metabolite; liquid chromatography-tandem
mass spectrometry for amphetamines and opiates) at an additional
charge. If only oxycodone screens positive, only confirmation of
oxycodone w/metabolite will be performed. Any other opiate-
positive screen will result in the full opiate confirmation being
performed.

The drug screen, prescription/OTC will be performed by gas
chromatography-mass spectrometry. Qualitative results will be
reported.

Reporting Name

Pain Clinic Drug Screen, U

Specimen Type

Urine

Specimen Required

Collection Container/Tube: Plastic urine container

Submission
Container/Tube: Plastic, 60-mL urine bottle

Specimen Volume: 30 mL

Collection Instructions:

1. Collect a random urine specimen.

2. Submit 30 mL in 1 plastic bottle.

3. No preservative.

Additional
Information:

1. No specimen substitutions.

2. No STATS are accepted for this procedure.

3. For situations where chain of custody is required, a
Chain-of-Custody Kit (T282) is available. For chain-of-custody
testing, order PDSOX / Pain Clinic Drug Screen, Chain of Custody,
Urine.

5. If urine creatinine is required or adulteration of the sample
is suspected, the following test should be requested, ADULT /
Adulterants Survey, Urine. For additional information, please refer
to ADULT / Adulterants Survey, Urine.

6. Submitting less than 30 mL will compromise our ability to
perform all necessary testing.

Specimen Minimum Volume

25 mL

Specimen Stability Information

Specimen Type

Temperature

Time

Urine

Refrigerated (preferred)

14 days

Frozen

14 days

Ambient

72 hours

Reference Values

Negative

Screening cutoff concentrations:

Amphetamines: 500 ng/mL

Barbiturates: 200 ng/mL

Benzodiazepines: 100 ng/mL

Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL

Ethanol: 10 mg/dL

Methadone metabolite: 300 ng/mL

Opiates: 300 ng/mL

Phencyclidine: 25 ng/mL

Tetrahydrocannabinol carboxylic acid: 50 ng/mL

This report is intended for use in clinical monitoring or
management of patients. It is not intended for use in
employment-related testing.